United Kingdom Biotechnology & Medical Research

Amarin Corporation PLC (AMRN)

Ticker: AMRN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Amarin Corporation PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.9
Berg Aaron President and CEO Officer
Transaction date
Purchase
Price
346.64
Quantity 58,973 -29.4%
Value US$2,872,748
1.3
Holt Patrick President and CEO Executive Director
Transaction date
Purchase
Price
328.92
Quantity 73,694 -2.9%
Value US$4,636,407
Ketchum Steven B Chief Scientific Officer Officer
Transaction date
Planned sale
Price
90.24
Quantity 24,287 -35.0%
Value US$3,867,757
STEVEN B. KETCHUM Officer Officer
Transaction date
Proposed sale
Price
0.84
Quantity 34,131
Value US$28,564
1.3
Holt Patrick President and CEO Executive Director
Transaction date
Purchase
Price
1.06
Quantity 67,222 +28.9%
Value US$71,255
1.3
Holt Patrick President and CEO Executive Director
Transaction date
Purchase
Price
1.06
Quantity 25,845 +12.4%
Value US$27,266
1.3
Holt Patrick President and CEO Executive Director
Transaction date
Purchase
Price
1.05
Quantity 12,700 +6.5%
Value US$13,335
1.3
Holt Patrick President and CEO Executive Director
Transaction date
Purchase
Price
1.04
Quantity 30,642 +18.7%
Value US$31,868
1.3
Holt Patrick President and CEO Executive Director
Transaction date
Purchase
Price
1.04
Quantity 19,358 +13.4%
Value US$20,036
1.3
Holt Patrick President and CEO Executive Director
Transaction date
Purchase
Price
1.03
Quantity 143,275 +14955.6%
Value US$147,573
1.3
Holt Patrick President and CEO Executive Director
Transaction date
Purchase
Price
1.03
Quantity 958 New position
Value US$982
1.4
WOLD OLSEN PER Non-Executive Director
Transaction date
Purchase
Price
1.69
Quantity 55,000 +58.5%
Value US$92,730
4.3
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
3.16
Quantity 2,000 +1.0%
Value US$6,310
4.3
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
3.27
Quantity 10,000 +5.4%
Value US$32,689
2.9
STACK DAVID M Non-Executive Director
Transaction date
Purchase
Price
4.54
Quantity 10,000 +33.3%
Value US$45,350
2.9
STACK DAVID M Non-Executive Director
Transaction date
Purchase
Price
4.62
Quantity 5,000 +20.0%
Value US$23,115
Ketchum Steven B Chief Scientific Officer Officer
Transaction date
Planned sale
Price
8.03
Quantity 25,370 -6.2%
Value US$203,670
Ketchum Steven B Chief Scientific Officer Officer
Transaction date
Planned sale
Price
8.06
Quantity 192,358 -32.0%
Value US$1,550,463
Ketchum Steven B Chief Scientific Officer Officer
Transaction date
Planned sale
Price
8.01
Quantity 143,392 -27.0%
Value US$1,149,258
Ketchum Steven B Chief Scientific Officer Officer
Transaction date
Planned sale
Price
8.01
Quantity 278,237 -34.4%
Value US$2,228,873
2.9
STACK DAVID M Non-Executive Director
Transaction date
Purchase
Price
4.86
Quantity 25,000 New position
Value US$121,518
1.3
THERO JOHN F President and CEO Executive Director
Transaction date
Sale
Price
4.07
Quantity 413,565 -13.1%
Value US$1,681,183
1.3
THERO JOHN F President and CEO Executive Director
Transaction date
Sale
Price
4.13
Quantity 153,840 -4.7%
Value US$635,975
1.3
THERO JOHN F President and CEO
Transaction date
Planned sale
Price
15.99
Quantity 200,000 -7.5%
Value US$3,198,700
4.3
Zakrzewski Joseph S
Transaction date
Planned sale
Price
20.94
Quantity 300,000 -78.0%
Value US$6,282,870
Zakrzewski Joseph S Non-Executive Director
Transaction date
Planned sale
Price
25.83
Quantity 100,000 -54.2%
Value US$2,583,380
Berg Aaron CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
25.46
Quantity 43,253 -24.4%
Value US$1,101,364
Kalb Michael Wayne SVP and CFO Officer
Transaction date
Planned sale
Price
25.66
Quantity 100 -0.5%
Value US$2,566
Kalb Michael Wayne SVP and CFO Officer
Transaction date
Planned sale
Price
24.84
Quantity 1,000 -4.4%
Value US$24,836
Kalb Michael Wayne SVP and CFO Officer
Transaction date
Planned sale
Price
23.81
Quantity 7,500 -24.9%
Value US$178,586
Kalb Michael Wayne SVP and CFO Officer
Transaction date
Planned sale
Price
23.05
Quantity 16,400 -35.2%
Value US$378,023
THERO JOHN F President and CEO Executive Director
Transaction date
Planned sale
Price
22.65
Quantity 274,454 -10.5%
Value US$6,217,371
Ekman Lars Non-Executive Director
Transaction date
Planned sale
Price
19.35
Quantity 38,600 -100.0%
Value US$746,759
THERO JOHN F President and CEO Executive Director
Transaction date
Planned sale
Price
17.88
Quantity 41,741 -1.6%
Value US$746,296
THERO JOHN F President and CEO Executive Director
Transaction date
Planned sale
Price
17.05
Quantity 433,805 -14.0%
Value US$7,397,156
Ekman Lars
Transaction date
Planned sale
Price
18.00
Quantity 6,400 -100.0%
Value US$115,230
Ekman Lars
Transaction date
Planned sale
Price
15.01
Quantity 91,016 -100.0%
Value US$1,365,722
2.9
STACK DAVID M
Transaction date
Planned sale
Price
22.28
Quantity 51,991 -100.0%
Value US$1,158,354
4.3
Zakrzewski Joseph S
Transaction date
Planned sale
Price
23.82
Quantity 100,000 -54.2%
Value US$2,381,580
0.9
Berg Aaron CHIEF COMMERCIAL OFFICER
Transaction date
Planned sale
Price
22.64
Quantity 29,250 -44.6%
Value US$662,238
0.9
Berg Aaron CHIEF COMMERCIAL OFFICER
Transaction date
Planned sale
Price
21.42
Quantity 19,564 -35.0%
Value US$419,061
0.9
Berg Aaron CHIEF COMMERCIAL OFFICER
Transaction date
Planned sale
Price
20.46
Quantity 50,000 -47.2%
Value US$1,023,080
Kennedy Joseph T General Counsel
Transaction date
Planned sale
Price
19.52
Quantity 54,186 -63.4%
Value US$1,057,906
Kalb Michael Wayne SVP and CFO
Transaction date
Planned sale
Price
19.67
Quantity 50,000 -70.6%
Value US$983,270
0.9
Berg Aaron CHIEF COMMERCIAL OFFICER
Transaction date
Planned sale
Price
18.59
Quantity 113,195 -75.7%
Value US$2,104,521
4.3
Zakrzewski Joseph S
Transaction date
Planned sale
Price
19.02
Quantity 100,000 -54.2%
Value US$1,902,090
Kennedy Joseph T General Counsel
Transaction date
Planned sale
Price
17.92
Quantity 27,229 -46.6%
Value US$488,058
2.9
STACK DAVID M Non-Executive Director
Transaction date
Planned sale
Price
18.45
Quantity 33,799 -100.0%
Value US$623,534
2.9
STACK DAVID M Non-Executive Director
Transaction date
Planned sale
Price
18.00
Quantity 13,174 -100.0%
Value US$237,139
Kennedy Joseph T General Counsel
Transaction date
Planned sale
Price
18.69
Quantity 27,230 -46.6%
Value US$508,839
Ketchum Steven B Chief Scientific Officer Officer
Transaction date
Planned sale
Price
18.67
Quantity 9,541 -2.6%
Value US$178,107
Ketchum Steven B Chief Scientific Officer
Transaction date
Planned sale
Price
20.78
Quantity 100 -0.0%
Value US$2,078
Ketchum Steven B Chief Scientific Officer
Transaction date
Planned sale
Price
20.05
Quantity 9,442 -2.6%
Value US$189,314
Kennedy Joseph T General Counsel
Transaction date
Planned sale
Price
20.03
Quantity 53,060 -62.1%
Value US$1,062,993
Ekman Lars
Transaction date
Planned sale
Price
21.71
Quantity 36,700 -100.0%
Value US$796,830
Ekman Lars
Transaction date
Planned sale
Price
21.16
Quantity 98,677 -72.9%
Value US$2,088,074
1.3
THERO JOHN F President and CEO Executive Director
Transaction date
Planned sale
Price
21.70
Quantity 70,673 -3.3%
Value US$1,533,894
1.3
THERO JOHN F President and CEO Executive Director
Transaction date
Planned sale
Price
21.15
Quantity 179,327 -7.7%
Value US$3,793,340
Kalb Michael Wayne SVP and CFO Officer
Transaction date
Planned sale
Price
22.59
Quantity 22,075 -51.8%
Value US$498,582
Kalb Michael Wayne SVP and CFO Officer
Transaction date
Planned sale
Price
22.06
Quantity 70,801 -62.4%
Value US$1,561,721
Kalb Michael Wayne SVP and CFO Officer
Transaction date
Planned sale
Price
20.89
Quantity 7,124 -5.9%
Value US$148,795
Ketchum Steven B Chief Scientific Officer Officer
Transaction date
Planned sale
Price
22.64
Quantity 7,099 -2.0%
Value US$160,717
Ketchum Steven B Chief Scientific Officer Officer
Transaction date
Planned sale
Price
22.10
Quantity 35,398 -8.9%
Value US$782,197
Ketchum Steven B Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.94
Quantity 3,503 -0.9%
Value US$73,361
Kennedy Joseph T General Counsel Officer
Transaction date
Planned sale
Price
20.72
Quantity 27,231 -46.6%
Value US$564,172
Ketchum Steven B Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.67
Quantity 9,543 -2.6%
Value US$197,249
Peterson Kristine Non-Executive Director
Transaction date
Planned sale
Price
20.02
Quantity 163,500 -100.0%
Value US$3,274,038
4.3
Zakrzewski Joseph S Non-Executive Director
Transaction date
Planned sale
Price
19.90
Quantity 180,625 -68.1%
Value US$3,594,438
Kalb Michael Wayne SVP and CFO Officer
Transaction date
Planned sale
Price
18.97
Quantity 50,000 -70.9%
Value US$948,500
3.4
VAN HEEK G JAN Non-Executive Director
Transaction date
Planned sale
Price
20.02
Quantity 203,382 -93.5%
Value US$4,071,423
Kalb Michael Wayne SVP and CFO Officer
Transaction date
Planned sale
Price
17.58
Quantity 25,000 -54.9%
Value US$439,525
Ketchum Steven B Chief Scientific Officer Officer
Transaction date
Planned sale
Price
17.06
Quantity 27,989 -7.3%
Value US$477,498
Kennedy Joseph T General Counsel Officer
Transaction date
Planned sale
Price
17.49
Quantity 42,624 -57.7%
Value US$745,468
Ketchum Steven B Chief Scientific Officer Officer
Transaction date
Planned sale
Price
17.49
Quantity 9,541 -2.7%
Value US$166,875
Kennedy Joseph T General Counsel Officer
Transaction date
Planned sale
Price
17.66
Quantity 609,115 -100.0%
Value US$10,754,717
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-05 2024-08-02 B Purchase
0.9
Berg Aaron

President and CEO

Officer
58,973 -29.4%
346.64
US$2,872,748 		58,973 -29.4% 346.64 US$2,872,748
2024-01-24 2024-01-22 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
73,694 -2.9%
328.92
US$4,636,407 		73,694 -2.9% 328.92 US$4,636,407
2023-12-14 2023-12-12 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
24,287 -35.0%
90.24
US$3,867,757 		24,287 -35.0% 90.24 US$3,867,757
2023-12-12 2023-12-12 PrS Proposed sale
STEVEN B. KETCHUM

Officer

Officer
34,131
0.84
US$28,564 		34,131 0.84 US$28,564
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
67,222 +28.9%
1.06
US$71,255 		67,222 +28.9% 1.06 US$71,255
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
25,845 +12.4%
1.06
US$27,266 		25,845 +12.4% 1.06 US$27,266
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
12,700 +6.5%
1.05
US$13,335 		12,700 +6.5% 1.05 US$13,335
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
30,642 +18.7%
1.04
US$31,868 		30,642 +18.7% 1.04 US$31,868
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
19,358 +13.4%
1.04
US$20,036 		19,358 +13.4% 1.04 US$20,036
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
143,275 +14955.6%
1.03
US$147,573 		143,275 +14955.6% 1.03 US$147,573
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
958 New position
1.03
US$982 		958 New position 1.03 US$982
2022-06-15 2022-06-13 B Purchase
1.4
WOLD OLSEN PER
Non-Executive Director
55,000 +58.5%
1.69
US$92,730 		55,000 +58.5% 1.69 US$92,730
2021-12-16 2021-12-15 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
2,000 +1.0%
3.16
US$6,310 		2,000 +1.0% 3.16 US$6,310
2021-12-16 2021-12-14 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
10,000 +5.4%
3.27
US$32,689 		10,000 +5.4% 3.27 US$32,689
2021-06-07 2021-06-04 B Purchase
2.9
STACK DAVID M
Non-Executive Director
10,000 +33.3%
4.54
US$45,350 		10,000 +33.3% 4.54 US$45,350
2021-06-07 2021-06-03 B Purchase
2.9
STACK DAVID M
Non-Executive Director
5,000 +20.0%
4.62
US$23,115 		5,000 +20.0% 4.62 US$23,115
2021-02-03 2021-02-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
25,370 -6.2%
8.03
US$203,670 		25,370 -6.2% 8.03 US$203,670
2021-02-03 2021-02-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
192,358 -32.0%
8.06
US$1,550,463 		192,358 -32.0% 8.06 US$1,550,463
2021-01-29 2021-01-27 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
143,392 -27.0%
8.01
US$1,149,258 		143,392 -27.0% 8.01 US$1,149,258
2021-01-29 2021-01-27 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
278,237 -34.4%
8.01
US$2,228,873 		278,237 -34.4% 8.01 US$2,228,873
2020-12-02 2020-11-30 B Purchase
2.9
STACK DAVID M
Non-Executive Director
25,000 New position
4.86
US$121,518 		25,000 New position 4.86 US$121,518
2020-11-12 2020-11-11 S Sale
1.3
THERO JOHN F

President and CEO

Executive Director
413,565 -13.1%
4.07
US$1,681,183 		413,565 -13.1% 4.07 US$1,681,183
2020-11-12 2020-11-10 S Sale
1.3
THERO JOHN F

President and CEO

Executive Director
153,840 -4.7%
4.13
US$635,975 		153,840 -4.7% 4.13 US$635,975
2020-03-06 2020-03-04 PlS Planned sale
1.3
THERO JOHN F

President and CEO
200,000 -7.5%
15.99
US$3,198,700 		200,000 -7.5% 15.99 US$3,198,700
2020-01-03 2020-01-03 PlS Planned sale
4.3
Zakrzewski Joseph S
300,000 -78.0%
20.94
US$6,282,870 		300,000 -78.0% 20.94 US$6,282,870
2019-12-18 2019-12-16 PlS Planned sale Zakrzewski Joseph S Non-Executive Director
100,000 -54.2%
25.83
US$2,583,380 		100,000 -54.2% 25.83 US$2,583,380
2019-12-18 2019-12-16 PlS Planned sale Berg Aaron

CHIEF COMMERCIAL OFFICER

Officer
43,253 -24.4%
25.46
US$1,101,364 		43,253 -24.4% 25.46 US$1,101,364
2019-12-18 2019-12-16 PlS Planned sale Kalb Michael Wayne

SVP and CFO

Officer
100 -0.5%
25.66
US$2,566 		100 -0.5% 25.66 US$2,566
2019-12-18 2019-12-16 PlS Planned sale Kalb Michael Wayne

SVP and CFO

Officer
1,000 -4.4%
24.84
US$24,836 		1,000 -4.4% 24.84 US$24,836
2019-12-18 2019-12-16 PlS Planned sale Kalb Michael Wayne

SVP and CFO

Officer
7,500 -24.9%
23.81
US$178,586 		7,500 -24.9% 23.81 US$178,586
2019-12-18 2019-12-16 PlS Planned sale Kalb Michael Wayne

SVP and CFO

Officer
16,400 -35.2%
23.05
US$378,023 		16,400 -35.2% 23.05 US$378,023
2019-11-21 2019-11-19 PlS Planned sale THERO JOHN F

President and CEO

Executive Director
274,454 -10.5%
22.65
US$6,217,371 		274,454 -10.5% 22.65 US$6,217,371
2019-11-13 2019-11-12 PlS Planned sale Ekman Lars Non-Executive Director
38,600 -100.0%
19.35
US$746,759 		38,600 -100.0% 19.35 US$746,759
2019-11-13 2019-11-11 PlS Planned sale THERO JOHN F

President and CEO

Executive Director
41,741 -1.6%
17.88
US$746,296 		41,741 -1.6% 17.88 US$746,296
2019-11-13 2019-11-11 PlS Planned sale THERO JOHN F

President and CEO

Executive Director
433,805 -14.0%
17.05
US$7,397,156 		433,805 -14.0% 17.05 US$7,397,156
2019-11-07 2019-11-05 PlS Planned sale
Ekman Lars
6,400 -100.0%
18.00
US$115,230 		6,400 -100.0% 18.00 US$115,230
2019-09-05 2019-09-03 PlS Planned sale
Ekman Lars
91,016 -100.0%
15.01
US$1,365,722 		91,016 -100.0% 15.01 US$1,365,722
2019-07-12 2019-07-11 PlS Planned sale
2.9
STACK DAVID M
51,991 -100.0%
22.28
US$1,158,354 		51,991 -100.0% 22.28 US$1,158,354
2019-07-05 2019-07-05 PlS Planned sale
4.3
Zakrzewski Joseph S
100,000 -54.2%
23.82
US$2,381,580 		100,000 -54.2% 23.82 US$2,381,580
2019-07-03 2019-07-03 PlS Planned sale
0.9
Berg Aaron

CHIEF COMMERCIAL OFFICER
29,250 -44.6%
22.64
US$662,238 		29,250 -44.6% 22.64 US$662,238
2019-07-03 2019-07-02 PlS Planned sale
0.9
Berg Aaron

CHIEF COMMERCIAL OFFICER
19,564 -35.0%
21.42
US$419,061 		19,564 -35.0% 21.42 US$419,061
2019-07-03 2019-07-02 PlS Planned sale
0.9
Berg Aaron

CHIEF COMMERCIAL OFFICER
50,000 -47.2%
20.46
US$1,023,080 		50,000 -47.2% 20.46 US$1,023,080
2019-07-03 2019-07-01 PlS Planned sale
Kennedy Joseph T

General Counsel
54,186 -63.4%
19.52
US$1,057,906 		54,186 -63.4% 19.52 US$1,057,906
2019-07-03 2019-07-01 PlS Planned sale
Kalb Michael Wayne

SVP and CFO
50,000 -70.6%
19.67
US$983,270 		50,000 -70.6% 19.67 US$983,270
2019-06-26 2019-06-24 PlS Planned sale
0.9
Berg Aaron

CHIEF COMMERCIAL OFFICER
113,195 -75.7%
18.59
US$2,104,521 		113,195 -75.7% 18.59 US$2,104,521
2019-06-20 2019-06-18 PlS Planned sale
4.3
Zakrzewski Joseph S
100,000 -54.2%
19.02
US$1,902,090 		100,000 -54.2% 19.02 US$1,902,090
2019-05-31 2019-05-31 PlS Planned sale
Kennedy Joseph T

General Counsel
27,229 -46.6%
17.92
US$488,058 		27,229 -46.6% 17.92 US$488,058
2019-05-31 2019-05-29 PlS Planned sale
2.9
STACK DAVID M
Non-Executive Director
33,799 -100.0%
18.45
US$623,534 		33,799 -100.0% 18.45 US$623,534
2019-05-21 2019-05-17 PlS Planned sale
2.9
STACK DAVID M
Non-Executive Director
13,174 -100.0%
18.00
US$237,139 		13,174 -100.0% 18.00 US$237,139
2019-05-02 2019-04-30 PlS Planned sale
Kennedy Joseph T

General Counsel
27,230 -46.6%
18.69
US$508,839 		27,230 -46.6% 18.69 US$508,839
2019-05-02 2019-04-30 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
9,541 -2.6%
18.67
US$178,107 		9,541 -2.6% 18.67 US$178,107
2019-04-01 2019-04-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer
100 -0.0%
20.78
US$2,078 		100 -0.0% 20.78 US$2,078
2019-04-01 2019-04-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer
9,442 -2.6%
20.05
US$189,314 		9,442 -2.6% 20.05 US$189,314
2019-04-01 2019-04-01 PlS Planned sale
Kennedy Joseph T

General Counsel
53,060 -62.1%
20.03
US$1,062,993 		53,060 -62.1% 20.03 US$1,062,993
2019-03-06 2019-03-04 PlS Planned sale
Ekman Lars
36,700 -100.0%
21.71
US$796,830 		36,700 -100.0% 21.71 US$796,830
2019-03-06 2019-03-04 PlS Planned sale
Ekman Lars
98,677 -72.9%
21.16
US$2,088,074 		98,677 -72.9% 21.16 US$2,088,074
2019-03-06 2019-03-04 PlS Planned sale
1.3
THERO JOHN F

President and CEO

Executive Director
70,673 -3.3%
21.70
US$1,533,894 		70,673 -3.3% 21.70 US$1,533,894
2019-03-06 2019-03-04 PlS Planned sale
1.3
THERO JOHN F

President and CEO

Executive Director
179,327 -7.7%
21.15
US$3,793,340 		179,327 -7.7% 21.15 US$3,793,340
2019-03-01 2019-03-01 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
22,075 -51.8%
22.59
US$498,582 		22,075 -51.8% 22.59 US$498,582
2019-03-01 2019-03-01 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
70,801 -62.4%
22.06
US$1,561,721 		70,801 -62.4% 22.06 US$1,561,721
2019-03-01 2019-03-01 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
7,124 -5.9%
20.89
US$148,795 		7,124 -5.9% 20.89 US$148,795
2019-03-01 2019-03-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
7,099 -2.0%
22.64
US$160,717 		7,099 -2.0% 22.64 US$160,717
2019-03-01 2019-03-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
35,398 -8.9%
22.10
US$782,197 		35,398 -8.9% 22.10 US$782,197
2019-03-01 2019-03-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
3,503 -0.9%
20.94
US$73,361 		3,503 -0.9% 20.94 US$73,361
2019-03-01 2019-02-28 PlS Planned sale
Kennedy Joseph T

General Counsel

Officer
27,231 -46.6%
20.72
US$564,172 		27,231 -46.6% 20.72 US$564,172
2019-03-01 2019-02-28 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
9,543 -2.6%
20.67
US$197,249 		9,543 -2.6% 20.67 US$197,249
2019-02-22 2019-02-22 PlS Planned sale
Peterson Kristine
Non-Executive Director
163,500 -100.0%
20.02
US$3,274,038 		163,500 -100.0% 20.02 US$3,274,038
2019-02-22 2019-02-22 PlS Planned sale
4.3
Zakrzewski Joseph S
Non-Executive Director
180,625 -68.1%
19.90
US$3,594,438 		180,625 -68.1% 19.90 US$3,594,438
2019-02-22 2019-02-22 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
50,000 -70.9%
18.97
US$948,500 		50,000 -70.9% 18.97 US$948,500
2019-02-22 2019-02-22 PlS Planned sale
3.4
VAN HEEK G JAN
Non-Executive Director
203,382 -93.5%
20.02
US$4,071,423 		203,382 -93.5% 20.02 US$4,071,423
2019-02-15 2019-02-15 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
25,000 -54.9%
17.58
US$439,525 		25,000 -54.9% 17.58 US$439,525
2019-02-01 2019-02-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
27,989 -7.3%
17.06
US$477,498 		27,989 -7.3% 17.06 US$477,498
2019-02-01 2019-01-31 PlS Planned sale
Kennedy Joseph T

General Counsel

Officer
42,624 -57.7%
17.49
US$745,468 		42,624 -57.7% 17.49 US$745,468
2019-02-01 2019-01-31 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
9,541 -2.7%
17.49
US$166,875 		9,541 -2.7% 17.49 US$166,875
2019-01-24 2019-01-24 PlS Planned sale
Kennedy Joseph T

General Counsel

Officer
609,115 -100.0%
17.66
US$10,754,717 		609,115 -100.0% 17.66 US$10,754,717

See older Amarin Corporation PLC insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Amarin Corporation PLC history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Amarin Corporation PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe